This study investigates the immunological role of elevated IL-6 post-operatively. Although increased IL-6 is associated with post-operative infections, the immunosuppressive properties of post-operative serum are not reversed with IL-6 neutralisation but are with IFN-γ administration. Elevated post-operative IL-6 may represent an epiphenomenon in the context of post-operative immunosuppression.
Abstract Objective
To evaluate the role of IL-6 pathways in post-operative immune-suppression and to assess the reversibility of this phenomenon.
Background
The post-operative period is characterised by increased IL-6 production and features of immunesuppression. In vitro, IL-6 mediates anti-inflammatory effects through inhibition of interferon-gamma (IFN-γ) pathways. The significance of the immunomodulatory effects of IL-6 in the clinical setting of post-operative immune-suppression remains unclear.
Methods
Patients over 45 years old undergoing elective surgery involving the gastrointestinal tract were recruited. IL-6 levels were assayed using ELISA pre-operatively, at 24 and 48hrs. Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were cultured in perioperative serum and
CD14
+ HLA-DR (mHLA-DR) geometric-mean florescent intensity (MFI) was measured in the presence and absence of IL-6 neutralising antibody and recombinant IFN-γ.
Results
Of 108 patients, 41 developed a post-operative infection. IL-6 levels increased 19-fold from the pre-operative sample to 24hrs post-operatively (P<0.0001). Higher IL-6 levels at 24 (P=0.0002) and 48hrs (P=0.003) were associated with subsequent post-operative infectious complications. mHLA-DR MFI fell when healthy PBMCs were cultured with post-operative serum compared to pre-operative serum (P=0.008). This decrease was prevented by the presence of IFN-γ in the culture media but not by the presence of IL-6 neutralising antibody.
Introduction
Following major surgery patients experience a period of immune suppression, which can predispose to the development of post-operative infections. 1 Infectious complications result in considerable morbidity and are observed in over 30% of older patients undergoing major surgery. 2 Postoperative immune dysfunction is mediated partly by tissue injury and the consequent release of intracellular alarmins such as mitochondrial DNA fragments. 3 The cellular and transcriptomic features of tissue damage induced immune modulation are now well characterised. [4] [5] [6] Key reproducible cellular features of this response include a consistent fall in monocyte HLA-DR (mHLA-DR) expression 1, 7, 8 and an expansion of cells with phenotypic similarities to myeloid derived suppressor cells. 4, 5, 9 These alterations are quantitatively associated with infectious complications and poor functional recovery. 1, 4, 8 Although the immune suppressive effect of major tissue damage has been shown to be reversible with interferon gamma (IFN-γ) treatment in the context of traumatic injuries, [10] [11] [12] in the perioperative period the specific additional immunomodulating effects attributable to such factors as prolonged anaesthetic administration, opioid analgesics, premorbid conditions and blood transfusion require further consideration. [13] [14] [15] There is similar consistency amongst the transcriptomic data available following tissue damage and major surgery. 6, 16, 17 A striking feature is the elevation in IL-6 levels in patients with features of functional immune suppression and the correlation between circulating levels of this cytokine and infectious complications. Although many essential pro-inflammatory effects are mediated through IL-6 pathways this cytokine has also been shown to drive differentiation of T helper cells to a T helper cell type 2 (T h 2) subtype and to inhibit T h 1 maturation through a Suppressor of Cytokine Signalling 1 (SOCS1) dependent suppression of IFN-γ signalling. 18, 19 These latter effects could be broadly construed as anti-inflammatory and may induce an immune environment in which host bactericidal abilities are impaired, thereby increasing susceptibility to infectious complications. Furthermore, the purported mechanism of action suggests that restoring IFN-γ activity may reverse the downstream consequences.
We hypothesised that increased levels of IL-6 following major surgery may promote an immunosuppressed phenotype that can be reversed with IFN-γ. In order to explore this hypothesis we aimed to describe the patterns of IL-6 production in response to major gastrointestinal surgery and the relationship between IL-6 levels and infectious complications. We also aimed to explore the role of IL-6 dependent pathways in post-operative immune suppression and to determine whether this immune suppression might be reversed by IFN-γ.
Methods
This study was conducted at The Royal London Hospital, London UK and approved by the North Wales Research Ethics Committee (Reference: 10/WNo03/25).
Patient selection
Consecutive patients aged over 45 years undergoing scheduled surgery involving the gastrointestinal tract, requiring a general anaesthetic and at least an overnight hospital stay were considered eligible for inclusion to this study. Exclusion criteria were refused consent, emergency surgery and surgery which also involved access to the thoracic cavity. Every patient on a weekday elective operating list was screened. Eligible patients were then approached for written informed consent. Entry into the study did not influence clinical treatment. All patients received perioperative prophylactic antibiotic therapy.
Data collection
Clinical data were collected on each patient until hospital discharge. Pre-operative immunosuppression was defined as the administration of chemotherapeutic agents and/or radiotherapy within the six months preceding surgery. 
Enzyme Linked Immunosorbent Assay (ELISA)
Plasma samples were assayed in duplicate using commercially available IL-6 ELISAs (Life Technologies, Carlsbad, CA) with absorbance measured at 450nm. We have previously attempted to quantify IFN-γ levels in plasma from similar patient groups and found levels to be unreliably detectible in the majority of patients; consequently we chose not to attempt to measure IFN-γ levels in this population. Neutralising experiments: Pooled healthy PBMCs were pre-incubated with an Fc Block™ (Becton Dickinson, UK) for 30min then incubated with 30% 24hr serum and media pre-incubated with either IL-6 neutralising antibody 15ng/mL (AB-206-NA R&D systems, UK) for a minimum of 1 hour or with control non-specific goat IgG at 15ng/mL (AB-108-C, R&D systems, UK). These were cultured as described above.
In vitro cell culture experiments
IL-6 protein was quantified as above in four duplicate patient samples with and without 15ng/ml IL-6 neutralising antibody in order to demonstrate the efficacy of the neutralising effect (Supplementary figure 1).
Stimulating experiments: Pooled healthy PBMCs were incubated with 30% serum from either baseline or 24hrs with and without IFN-γ (250 International Units, R&D systems, UK). These were cultured as described above. 
Flow Cytometry

Statistical analysis
Results are expressed as median and interquartile range (IQR). All statistical tests are two-sided and a P-value of P<0.05 was considered significant. Differences in categorical variables were calculated using a Chi-squared or Fisher's exact test as appropriate. The Kruskal-Wallis test was used for continuous variables and the Wilcoxon signed-rank test for repeated measurements. Multivariable linear regression models were used to assess whether IL-6 levels were independently associated with post-operative infection. Data analysis was performed using the JMP (version 11) statistical software package (SAS, Cary, NC, USA).
Results
Patients
108 patients (mean age 65, range 46-87, 59% male) undergoing elective major abdominal surgery were included in this study. 41 (38%) patients developed a post-operative infection. Patient characteristics are outlined in Table 1 .
Post-operative infections
Post-operative infectious complications developed a median of 9 (IQR 5-11) days following the procedure. The sites of infection and organisms isolated are shown in Table 2 .
Patients developing infections stayed longer in hospital (14 (9-19) vs 7 (5-9) days, P<0.0001). A range of demographic and
clinical data did not distinguish between those who did and did not develop infection (Table 1) .
Perioperative IL-6 levels
IL-6 levels increased 19-fold from baseline to 24 hours post-operatively (P<0.0001) and were unchanged between 24 and 48 hours post-operatively ( Figure 2A ). Baseline IL-6 levels were higher in patients with a diagnosis of cancer, P=0.02; Figure 2B ). None of age, sex, smoking history, immunosuppression or diabetes was associated with baseline IL-6 levels. At 24 hours higher IL-6 levels were observed in patients who would subsequently develop infections (P<0.0001; Figure 3A ). This association was observed for intra-abdominal infections (P=0.004; Figure 3B ) and surgical site infections (P=0.001; Figure 3C ) but not for pneumonia (P=0.81; Figure 3D ). IL-6 levels at 24 hours were directly 
Discussion
In this study we determined plasma levels of IL-6 protein in patients over 45 years of age undergoing elective surgery involving the gastrointestinal tract and described an independent association between higher post-operative levels of IL-6 and later nosocomial infections. We also demonstrated that serum collected in the post-operative period contains soluble mediators, which reduce the antigen presenting capabilities of healthy monocytes as measured by HLA-DR expression. Although the causative molecules and pathways remain unidentified we report that IL-6 dependent pathways are not essential mediators of this immune suppressed phenotype. Treatment with IFN-γ in vitro did, however, reverse the induced deficit in the antigen presenting capabilities of monocytes exposed to post-operative serum.
The association between IL-6 levels and post-operative infections is not unexpected and has been previously described. 21, 22 Unsurprisingly, we also report that IL-6 levels are higher in those patients undergoing lengthier procedures, which are likely to be more complex with a higher probability of postoperative complications. Importantly, however, we have found that the association between IL-6 levels and post-operative infections is independent of the duration of the surgical procedure. It is also well recognised that post-operative patients display features of immune suppression. 1, 7 However, whereas previous investigators have reported alterations in the properties of specific cell subtypes or their cell surface markers 4, 7 we demonstrate that immune suppression is mediated, at least in part, by soluble compounds that remain 24 hours following surgery, as opposed to the direct effect of either tissue damage, anaesthesia or endotoxin release on immune cell subtypes. These data may be of crucial importance in developing potential treatments to alleviate post-operative immune suppression.
The key link between the tissue damage characteristic of major surgery and the subsequent inflammatory response is the release of alarmins. 23 Alarmins are a group of structurally diverse compounds, which include high-mobility-group box (HMGB) proteins and mitochondrial DNA (mtDNA), which are released following tissue damage as cells undergo physiological stress or necrosis. monocyte population. 28 These same patients displayed higher resting and TLR-stimulated IL-6 levels in the early post-operative period in conjunction with enhanced activity in the NF-κB signaling pathway. 28 We further hypothesised that were IL-6 to play a major role in mediating post-operative immune suppression through a pathway that culminates in IFN-γ inhibition 19 There are a number of inherent strengths to our study. We have studied a clinically relevant atrisk population selected by using age over 45 years old as an inclusion criterion. This ensures that the event rate of our primary outcome, infectious complications following elective surgery, is sufficiently high at 38% and is in keeping with recent data from similar cohorts. 2 As all patients were undergoing elective surgery this allows each patient in the in vitro study to act as their own control. This is important as a significant number of these patients had a diagnosis of cancer or were immunocompromised and the use of healthy control serum as a comparator would be inappropriate. Finally, we describe a relatively novel method of identifying perioperative immune suppression by culturing healthy monocytes in postoperative serum in conjunction with the well-validated methodology of defining immune suppression by observing a decrease in mHLA-DR expression.
31, 32
Limitations of this study include; not assaying circulating IFN-γ protein levels in the postoperative period and the wide variability in the surgical procedures performed resulting in a heterogeneous patient population. We chose not to assay circulating IFN-γ protein levels due to the insensitivity of the IFN-γ assay in clinical conditions where in our experience IFN-γ levels are frequently undetectable. (1) 15 (3 -27) Data refer to the number of episodes of infection from a particular site. Some patients may have more than one episode of infection. The number in parenthesis in the organisms column the number of episodes of infection attributable to that organism. ESBL, Extended-spectrum beta-lactamase; MRSA, methicillin-resistant S. aureus; VRE, Vancomycin-resistant Enterococcus. Data are described as median and interquartile range. 1. Patient has a recognized pathogen cultured from 1 or more blood cultures.
Conclusions
AND organism cultured from blood is not related to an infection at another site.
2. Patient has at least 1 of the following signs or symptoms: fever (>38°C), chills, or hypotension.
AND signs and symptoms and positive laboratory results are not related to an infection at another site.
AND common skin contaminant is cultured from 2 or more blood cultures drawn on separate occasions.
Secondary Bloodstream Infection (BSI)
In a patient suspected of having an infection, blood and a site-specific specimen are collected for culture and both are positive for at least one matching organism. If the site-specific culture is an element used to meet the infection site criterion, then the BSI is considered secondary to that sitespecific infection. 
Supplementary
Supplementary Figure 1: Efficacy of the IL-6 blocking antibody
A: Changes in IL-6 protein concentration when post-operative serum was cultured in the presence or absence of an IL-6 blocking antibody. All data displayed as median and interquartile range, P<0.05 *.
